Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor.

Based on a lead compound identified from the patent literature, we developed patentably novel BACE-1 inhibitors by introducing a cyclic amine scaffold as embodied by 1a and 1b. Extensive SAR studies assessed a variety of isophthalamide replacements including substituted pyrrolidinones and ultimately led to the identification of 11. Due to its favorable overall profile, 11 has been extensively profiled in various in vivo settings.

[1]  M. Citron,et al.  Strategies for disease modification in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[2]  M. Luca,et al.  Molecular Rationale for the Pharmacological Treatment of Alzheimer’s Disease , 2005, Drugs & aging.

[3]  A. Tomasselli,et al.  Design of potent inhibitors of human beta-secretase. Part 1. , 2007, Bioorganic & medicinal chemistry letters.

[4]  L. Thompson,et al.  Progress in the discovery of BACE inhibitors. , 2005, Current pharmaceutical design.

[5]  Allen B. Reitz,et al.  BACE Inhibitors for the Treatment of Alzheimer's Disease , 2005 .

[6]  Y. Kiso,et al.  Views on amyloid hypothesis and secretase inhibitors for treating Alzheimer's disease: progress and problems. , 2006, Current pharmaceutical design.

[7]  D. Fairlie,et al.  Protease inhibitors: current status and future prospects. , 2000, Journal of medicinal chemistry.

[8]  M. Kennedy,et al.  Measuring human beta-secretase (BACE1) activity using homogeneous time-resolved fluorescence. , 2003, Analytical biochemistry.

[9]  S. Pricl,et al.  A chemoenzymatic approach to the synthesis of enantiomerically pure aza analogues of paraconic acid methyl ester and both enantiomers of methyl β-proline , 2001 .

[10]  T. Guo,et al.  Development of BACE1 inhibitors for Alzheimer's disease. , 2006, Current medicinal chemistry.

[11]  H. Amri,et al.  (Z)-Dimethyl α-(bromomethyl)fumarate, an efficient intermediate for the selective synthesis of dimethyl 3-alkyl itaconates and 2-alkyl 3-carbomethoxy-γ-lactams , 1999 .

[12]  M. Wolfe,et al.  Identity and function of γ‐secretase , 2003 .

[13]  J. Cumming,et al.  Design and development of BACE-1 inhibitors. , 2004, Current opinion in drug discovery & development.

[14]  E. Parker,et al.  Biochemical characterization of the gamma-secretase activity that produces beta-amyloid peptides. , 2001, Biochemistry.

[15]  A. Stamford,et al.  Potent pyrrolidine- and piperidine-based BACE-1 inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[16]  T. Shepherd,et al.  Progress toward the discovery and development of efficacious BACE inhibitors. , 2006, Current opinion in drug discovery & development.